Synthesis and in-vitro bioactivity evaluation of new galactose and fructose ester derivatives of 5-aminosalicylic acid

Inflammatory bowel disease (IBD) is the main risk factor for developing colorectal cancer which is common in patients of all ages. 5-aminosalicylic acid (5-ASA), structurally related to the salicylates, is highly active in the treatment of IBD with minor side effects. In this study, the synthesis of...

Full description

Bibliographic Details
Main Authors: Yousefi, Samira, Bayat, Saadi, Abdul Rahman, Mohd Basyaruddin, Ibrahim, Zalikha, Abdulmalek, Emilia
Format: Article
Language:English
Published: Wiley-VHCA AG, Zurich, Switzerland 2017
Subjects:
Online Access:http://irep.iium.edu.my/57352/
http://irep.iium.edu.my/57352/
http://irep.iium.edu.my/57352/
http://irep.iium.edu.my/57352/1/Samira%20et%20al%20%282017%29.pdf
id iium-57352
recordtype eprints
spelling iium-573522018-03-09T07:08:45Z http://irep.iium.edu.my/57352/ Synthesis and in-vitro bioactivity evaluation of new galactose and fructose ester derivatives of 5-aminosalicylic acid Yousefi, Samira Bayat, Saadi Abdul Rahman, Mohd Basyaruddin Ibrahim, Zalikha Abdulmalek, Emilia QD Chemistry Inflammatory bowel disease (IBD) is the main risk factor for developing colorectal cancer which is common in patients of all ages. 5-aminosalicylic acid (5-ASA), structurally related to the salicylates, is highly active in the treatment of IBD with minor side effects. In this study, the synthesis of galactose and fructose esters of 5-ASA was planned to evaluate the role of glycoconjugation on the bioactivity of the parent drug. The antibacterial activity of the new compounds were evaluated against two Gram-negative and two Gram-positive species of bacteria, with a notable effect observed against Staphylococcus aureus and Escherichia coli in comparisons with the 5-ASA. Cytotoxicity testing over HT-29 and 3T3 cell lines indicated that the toxicity of the new products against normal cells was significantly reduced compared with the original drug, whereas their activity against cancerous cells was slightly decreased. The anti-inflammatory activity test in RAW264.7 macrophage cells indicated that the inhibition of nitric oxide by both of the monosaccharide conjugated derivatives was slightly improved in comparison with the non-conjugated drug. Wiley-VHCA AG, Zurich, Switzerland 2017-03-20 Article PeerReviewed application/pdf en http://irep.iium.edu.my/57352/1/Samira%20et%20al%20%282017%29.pdf Yousefi, Samira and Bayat, Saadi and Abdul Rahman, Mohd Basyaruddin and Ibrahim, Zalikha and Abdulmalek, Emilia (2017) Synthesis and in-vitro bioactivity evaluation of new galactose and fructose ester derivatives of 5-aminosalicylic acid. Chemistry & Biodiversity, 14 (4). e1600362-1. ISSN 1612-1880 http://onlinelibrary.wiley.com/doi/10.1002/cbdv.201600362/full 10.1002/cbdv.201600362
repository_type Digital Repository
institution_category Local University
institution International Islamic University Malaysia
building IIUM Repository
collection Online Access
language English
topic QD Chemistry
spellingShingle QD Chemistry
Yousefi, Samira
Bayat, Saadi
Abdul Rahman, Mohd Basyaruddin
Ibrahim, Zalikha
Abdulmalek, Emilia
Synthesis and in-vitro bioactivity evaluation of new galactose and fructose ester derivatives of 5-aminosalicylic acid
description Inflammatory bowel disease (IBD) is the main risk factor for developing colorectal cancer which is common in patients of all ages. 5-aminosalicylic acid (5-ASA), structurally related to the salicylates, is highly active in the treatment of IBD with minor side effects. In this study, the synthesis of galactose and fructose esters of 5-ASA was planned to evaluate the role of glycoconjugation on the bioactivity of the parent drug. The antibacterial activity of the new compounds were evaluated against two Gram-negative and two Gram-positive species of bacteria, with a notable effect observed against Staphylococcus aureus and Escherichia coli in comparisons with the 5-ASA. Cytotoxicity testing over HT-29 and 3T3 cell lines indicated that the toxicity of the new products against normal cells was significantly reduced compared with the original drug, whereas their activity against cancerous cells was slightly decreased. The anti-inflammatory activity test in RAW264.7 macrophage cells indicated that the inhibition of nitric oxide by both of the monosaccharide conjugated derivatives was slightly improved in comparison with the non-conjugated drug.
format Article
author Yousefi, Samira
Bayat, Saadi
Abdul Rahman, Mohd Basyaruddin
Ibrahim, Zalikha
Abdulmalek, Emilia
author_facet Yousefi, Samira
Bayat, Saadi
Abdul Rahman, Mohd Basyaruddin
Ibrahim, Zalikha
Abdulmalek, Emilia
author_sort Yousefi, Samira
title Synthesis and in-vitro bioactivity evaluation of new galactose and fructose ester derivatives of 5-aminosalicylic acid
title_short Synthesis and in-vitro bioactivity evaluation of new galactose and fructose ester derivatives of 5-aminosalicylic acid
title_full Synthesis and in-vitro bioactivity evaluation of new galactose and fructose ester derivatives of 5-aminosalicylic acid
title_fullStr Synthesis and in-vitro bioactivity evaluation of new galactose and fructose ester derivatives of 5-aminosalicylic acid
title_full_unstemmed Synthesis and in-vitro bioactivity evaluation of new galactose and fructose ester derivatives of 5-aminosalicylic acid
title_sort synthesis and in-vitro bioactivity evaluation of new galactose and fructose ester derivatives of 5-aminosalicylic acid
publisher Wiley-VHCA AG, Zurich, Switzerland
publishDate 2017
url http://irep.iium.edu.my/57352/
http://irep.iium.edu.my/57352/
http://irep.iium.edu.my/57352/
http://irep.iium.edu.my/57352/1/Samira%20et%20al%20%282017%29.pdf
first_indexed 2023-09-18T21:21:04Z
last_indexed 2023-09-18T21:21:04Z
_version_ 1777411884928991232